Using sEMG of the Diaphragm to Assess Readiness for Extubation

NCT ID: NCT07110129

Last Updated: 2025-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As part of an admission to an Intensive Care Unit (ICU) many patients have breathing tube inserted into their windpipe, also referred to as intubation . This is done for a variety of reasons which can include the need for invasive breathing support and to place the patient into a medically induced coma to allow their body to rest and be treated for the underlying cause of their deterioration.

One the patient has started to recover from their illness, the process of removing the breathing tube (extubation) and stopping the breathing machine begins. Optimising this process and ensuring successful removal of the breathing tube is extremely important to optimise outcomes. Therefore, identifying new methods to determine the likelihood for successful extubation is of clinical significance.

There are several markers of extubation readiness that clinicians can use to support their decision making discussed in the literature. A novel method is the use of respiratory muscle activity monitoring via sensory electromyogram (sEMG). sEMG has previously been shown to be useful to measure the strength and activity of muscles. However, until recently measuring diaphragm activity has been a challenge due to noise from the chest movements, cardiac artefacts. Recent advancements in signal processing and growing interest in better diagnostic methods has led to an improvement in metrics. Using wavelet transforms and machine learning, new techniques have been developed to measure diaphragm muscle activity using sEMG. sEMG has been shown to be effective in detecting patient-ventilator asynchrony as well as respiratory strength in those not requiring mechanical ventilation. However, its use in assessing patients nearing readiness for extubation has not been explored.

Therefore, the purpose of this feasibility trial is to explore the use of sEMG in patients undergoing trials of extubation. The results of this study will be used to design a multi-site trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

150,000 patients a year in the UK need to be admitted to a critical care unit. Those admitted are usually either critically unwell or are in the recovery phase of a critical illness (1). Often patients will require support for one or more of their vital organs such as their lungs, heart or kidneys. Approximately 60% of patients admitted will require support from mechanical ventilation (breathing machine) (2).

Mechanical ventilation is lifesaving when indicated but is beset by potential complications as the duration increases (3). Early identification of patients who are ready to be liberated from ventilatory support is therefore key. However, clinician judgement lacks both sensitivity and specificity for identifying such patients.

A Cochrane review in 2010 (4) demonstrated protocolised and standardised weaning method reduced the duration of total mechanical ventilation by 25%, weaning duration time by 78% and Intensive Care Unit (ICU) length of stay by 10%. Conversely, prolonged weaning process worsens patient outcomes, increases the risk of dying, and increases length of ICU and hospital stay, affects finite critical care resource and a direct impact on financial cost and environment sustainability (5).

Predicting readiness for extubation is challenging. This task is best accomplished by means of a protocolised process including a spontaneous awakening trial (SAT) where sedation is lowered to a safe RASS target and a spontaneous-breathing trials (SBT), in which patients who meet a defined set of criteria undergo a test period of minimal (Pressure support ventilation) or no ventilator (T-piece) support (6). This is then frequently combined with objective markers or 'extubation indices'. These indices include assessments of breathing strength and endurance, cough strength and respiratory distress e.g., P0.1, MIP, Peak cough flow and RSBI. However, these indices have been shown to lack sensitivity and specificity, with none of them able to accurately predict readiness for extubation or likely success (7).

The incidence of extubation failure reported in literature is quite variable with \~5% in post-operative surgical units to 10% in medical ICUs. With each additional day without a weaning success after the first attempt, there is an associated increase in crude mortality. Crude mortality increased from 19.0% in patients not weaned one day after the first attempt to 36.8% in patients still present in the ICU and not successfully weaned 10 days after the first attempt (8). Studies have also demonstrated that patients requiring reintubation are at increased risk of death with mortality rates ranging as high as 43% compared with less than 12% in patients successfully extubated (9). Reintubation is associated with a 4.5 times increased risk of nosocomial pneumonia (10).

Therefore, identifying new methods for determine likelihood for successful extubation is of clinical importance. Once such novel method is the use of respiratory muscle activity monitoring via sensory electromyogram (sEMG). sEMG has previously been shown to be useful to measure the strength and activity of muscles (11). However, until recently measuring diaphragm activity has been a challenge due to noise from the chest movements, cardiac artifacts. Recent advancements in signal processing and growing interest in better diagnostic methods has led to an improvement in metrics (12). Using wavelet transforms and machine learning, new techniques have been developed to measure diaphragm muscle activity using surface EMG electrodes placed at the 6-8th intercostal space along the mid-axillary or mid-clavicular line (13). Indeed, a pilot study looking at the sEMG of the diaphragm in healthy humans has shown that we are able to predict the inspiratory load of 6 participants with over 70% accuracy. sEMG has also been shown to be effective in detecting patient-ventilator asynchrony as well as respiratory strength in those not requiring mechanical ventilation (14). However, its use in assessing patients nearing readiness for extubation has not been explored.

Therefore, the purpose of this feasibility trial is to explore the use of sEMG in patients undergoing trials of extubation. The results of this study will be used to design a multi-site trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Critical care cohort

Critical care cohort - all to have EMG completed. No other intervention

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients requiring mechanical ventilation for \>72 hours
* Patients who an attempt at extubation is planned
* Patients who are willing or able to give informed consent (Where consultee advice is sought, informed consent from the participant will be completed as soon as possible).

Exclusion Criteria

* Aged under 18 years
* Patients admitted with traumatic or spontaneous brain injury
* Patients for who extubation is planned as a palliative process
* Contra-indication to using sEMG e.g., permanent or temporary pacemaker, internal or external cardiac defibrillator, skin lesions around site of electrode placement
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cardiff and Vale University Health Board

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiff and Vale University Health Board

Cardiff, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paul Twose, PhD

Role: CONTACT

+447739315830

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Paul Twose

Role: primary

00447739315830

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRAS 353832

Identifier Type: OTHER

Identifier Source: secondary_id

8999

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.